SHH · 688176.SS
Jiangsu Yahong Meditech Co Ltd
CN¥11.07-CN¥0.08 (-0.72%)
Jiangsu Yahong Meditech Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 38.87% below the high.
Loading market information…
SHZ · 300485.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:15 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Beijing Science Sun Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.77% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Beijing Science Sun Pharmaceutical Co., Ltd.’s forward annual dividend is CN¥0.02 per share, paid annual. The forward yield is 0.28% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Beijing Science Sun Pharmaceutical Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Beijing Science Sun Pharmaceutical Co., Ltd. is a company, established in 1999 and headquartered in Beijing, China, that operates within the Chinese pharmaceutical market. It is dedicated to the research, development, manufacturing, and distribution of injectable medications. The firm offers a wide array of products designed to treat conditions related to the cardiovascular, cerebrovascular, immunomodulatory, and nervous systems, among other health areas.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:31 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥11.07-CN¥0.08 (-0.72%)
Jiangsu Yahong Meditech Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 38.87% below the high.
CN¥55.22+CN¥1.00 (+1.84%)
Beijing Sun-Novo Pharmaceutical Research Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.57% below the high.
CN¥6.91+CN¥0.13 (+1.92%)
Jinghua Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.95% below the high.
CN¥13.35+CN¥0.14 (+1.06%)
Chongqing Pharscin Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.67% below the high.
CN¥8.75+CN¥0.20 (+2.34%)
Teyi Pharmaceutical Group Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.47% below the high.
CN¥19.46-CN¥0.34 (-1.72%)
Shenzhen Weiguang Biological Products Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.41% below the high.
CN¥3.99+CN¥0.00 (0.0%)
Luoxin Pharmaceuticals Group Stock Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.44% below the high.
CN¥26.74+CN¥0.48 (+1.83%)
Jianmin Pharmaceutical Group Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.65% below the high.
